SCHEMBL197336

SCHEMBL197336

PC(Cc1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.48
SLC6A4 P31645 3/20 0.48
SLC6A3 Q01959 3/20 0.48
EPHX1 P07099 2/20 0.48
SIGMAR1 Q99720 3/20 0.45
ACP3 P15309 1/20 0.45
TAAR1 Q96RJ0 4/20 0.44
MAOA P21397 1/20 0.44
CYP2A6 P11509 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
HTR2A P28223 1/20 0.42
ADRA1A P35348 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15412771 0.95 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL30450909 0.91 SLC6A2 (0.42) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL6251036 0.80 MEN1 (0.54) SLC6A4SIGMAR1CYP1A2CYP2D6CYP2C19
SCHEMBL197100 0.76 ACP3 (0.48) SLC6A2SLC6A4SLC6A3SIGMAR1ACP3
SCHEMBL318537 0.76 SLC6A2 (0.74) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL9007218 0.76 EPHX1 (0.55) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL924819 0.76 SLC6A2 (0.74) SLC6A2SLC6A4SLC6A3EPHX1SIGMAR1
SCHEMBL13754798 0.76 HTR2A (0.44) SLC6A4SLC6A3TAAR1CYP1A2CYP2D6
SCHEMBL7769635 0.75 ACP3 (0.47) SLC6A2SLC6A4SLC6A3SIGMAR1ACP3
SCHEMBL1398395 0.75 ACP3 (0.47) SLC6A2SLC6A4SLC6A3SIGMAR1ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112154149-B New vinylphosphines and photoinitiators obtainable therefrom 汉斯约尔格·格吕茨马赫 2025-02-21 CN claimed
CN-112154149-A Novel vinylphosphines and photoinitiators obtainable therefrom 汉斯约尔格·格吕茨马赫 2020-12-29 CN claimed
US-8648000-B2 Diene polymerisation INEOS COMMERCIAL SERVICES UK LIMITED (GB) 2014-02-11 US claimed
WO-2013166348-A2 SURFACE MODIFICATION OF PIGMENTS AND COMPOSITIONS COMPRISING THE SAME CABOT CORPORATION (US) 2013-11-07 WO claimed
WO-2012035546-A3 A TAMPER EVIDENT MULTIPLE METALLIZED AND DEMETALLIZED SECURITY DEVICE AND PROCESS FOR PREPARING THE SAME KAPOOR AJAY (IN) 2012-05-10 WO claimed
EP-1532142-B1 POLYPEPTIDE CLEAVAGE PROCESS MEDTRONIC INC (US) 2012-03-21 EP claimed
EP-1918312-B1 Diene polymerisation INEOS COMMERCIAL SERVICES UK (GB) 2011-12-07 EP claimed
US-20080293896-A1 Diene polymerisation INEOS SALES (UK) LIMITED (GB) 2008-11-27 US claimed
EP-1918312-A1 Diene polymerisation INEOS EUROPE LIMITED (GB) 2008-05-07 EP claimed
WO-2003010179-A1 PROCESS FOR THE PREPARATION OF 2'-3'-DIDEOXY-2',3'-DIDEHYDRO-NUCLEOSIDES EMORY UNIVERSITY (US) 2003-02-06 WO claimed
EP-0851864-B1 NOVEL COUPLING AGENTS, PROCESSES FOR THEIR PREPARATION AND HAIR DYES SCHWARZKOPF GMBH HANS (DE) 2001-05-23 EP claimed
US-5961668-A 4-(2,4-diaminophenoxymethyl)-1,3-dioxolane secondary intermediates, processes for their production, and hair colorants HANS SCHWARZKOPF GMBH & CO. KG (DE) 1999-10-05 US claimed
US-5676706-A HYDROGEN PEROXIDE-FREE HAIR COLORS; COLORFASTNESS HANS SCHWARZKOPF GMBH & CO. KG. (DE) 1997-10-14 US claimed
EP-0709365-A1 Substituted 2,4-diaminophenols, process for their preparation and hair dyes containing them Hans Schwarzkopf GmbH (DE) 1996-05-01 EP claimed
US-4879070-A HYDROGEN, CARBON DIOXIDE, TERTIARY AMINE, RHODIUM-ORGANOPHOSPHORUS CATALYST BP CHEMICALS LIMITED (GB) 1989-11-07 US claimed
EP-0160544-A2 Process for the manufacture of conjugated polyenoic fatty compounds INDIAN EXPLOSIVES LIMITED (IN) 1985-11-06 EP claimed
US-12595274-B2 Method for manufacturing alkenyl phosphorus compound MARUZEN PETROCHEMICAL CO., LTD. (JP) 2026-04-07 US disclosed
US-20260085057-A1 SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS Bayer Pharma AG (DE) 2026-03-26 US disclosed
EP-0000315-B1 PROCESS FOR PREPARING OPTICALLY ACTIVE CITRONELLAL RHONE-POULENC INDUSTRIES (FR) 1980-09-17 EP disclosed
EP-0000315-A1 Process for preparing optically active citronellal RHONE-POULENC INDUSTRIES (FR) 1979-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085057-A1 SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS HRH4, BRCA1, HRH1 SLC6A2 4758/4885SLC6A4 4622/4885SLC6A3 4162/4885
US-12595274-B2 Method for manufacturing alkenyl phosphorus compound ACSL3, INPPL1, ARL1 SLC6A2 3973/4885SLC6A4 3466/4885SLC6A3 3823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.